ワルファリン抗凝固薬と妊娠

Prevention and treatment of venous thromboembolism--International Consensus Statement.

International angiology : a journal of the International Union of Angiology·2014

The use of intrapartum electronic fetal heart rate monitoring: a national survey.

Irish medical journal·2007

Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?

Gynecologic oncology·2006

Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.

Maturitas·2002

von Willebrand's disease: an important cause of dysfunctional uterine bleeding.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2002

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.

Climacteric : the journal of the International Menopause Society·2002

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Prenatal Fetal Growth Restriction and Cardiomyopathy Associated With an Unbalanced der(15)t(7;15): A Case Report.

Clinical case reports·2026

Primary Abdominal Ectopic Pregnancy Involving the Spleen: A Case Study.

Case reports in obstetrics and gynecology·2026

Frequency and Subtypes of <i>Blastocystis</i> in Patients with Diarrhea in Van, Türkiye 2022-2023.

Iranian journal of parasitology·2026

The Frequency of Severe Hemolytic Disease of the Fetus and Newborn Caused by Red Blood Cell Alloantibodies Undetected at the Antibodies Screening in the First Trimester: A Prospective Study.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2026

Endocardial Fibroelastosis as an Early and Isolated Ultrasound Marker of Anti-Ro/SSA(B) Antibodies in the Fetus.

Journal of clinical ultrasound : JCU·2026

Comparison between oral dydrogesterone versus no drugs in clinical outcome within the natural cycle-frozen-thawed embryo transfer cycle: a retrospective analysis.

BMC pregnancy and childbirth·2026

関連する実験動画

ワルファリン抗凝固薬と妊娠

関連する概念動画

Prevention and treatment of venous thromboembolism--International Consensus Statement.

The use of intrapartum electronic fetal heart rate monitoring: a national survey.

Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?

Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.

von Willebrand's disease: an important cause of dysfunctional uterine bleeding.

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Prenatal Fetal Growth Restriction and Cardiomyopathy Associated With an Unbalanced der(15)t(7;15): A Case Report.

Primary Abdominal Ectopic Pregnancy Involving the Spleen: A Case Study.

Frequency and Subtypes of <i>Blastocystis</i> in Patients with Diarrhea in Van, Türkiye 2022-2023.

The Frequency of Severe Hemolytic Disease of the Fetus and Newborn Caused by Red Blood Cell Alloantibodies Undetected at the Antibodies Screening in the First Trimester: A Prospective Study.

Endocardial Fibroelastosis as an Early and Isolated Ultrasound Marker of Anti-Ro/SSA(B) Antibodies in the Fetus.

Comparison between oral dydrogesterone versus no drugs in clinical outcome within the natural cycle-frozen-thawed embryo transfer cycle: a retrospective analysis.

関連する実験動画

ワルファリン抗凝固薬と妊娠

関連する概念動画

関連記事